Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Corvus Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- 0 vs. Q1 2024
- Shares held
- 27.6M
- +9.69M (+54.1%) vs. Q1 2024
- Total value
- $50.2M
- +$18.4M (+57.6%) vs. Q1 2024
- New holders
- 7
- 12 more added
- Sold out
- 7
- 10 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $36 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 24 | $44 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 53 | $96 | 0.00% | +36+211.8% | Added |
| Bank of America Corp | 392 | $713 | 0.00% | +392 | New |
| Advisor Group Holdings, Inc. | 534 | $971 | 0.00% | −666−55.5% | Reduced |
| Rhumbline Advisers | 791 | $1.44K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,212 | $4.00K | 0.00% | −7,134−76.3% | Reduced |
| Northwest Capital Management Inc | 3,397 | $6.18K | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 7,000 | $12.7K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 7,238 | $13.0K | 0.00% | +7,238 | New |
| JPMorgan Chase & Co | 9,152 | $16.7K | 0.00% | −43,672−82.7% | Reduced |
| Masso Torrence Wealth Management Inc. | 10,000 | $18.2K | 0.01% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 11,200 | $20.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,384 | $20.7K | 0.00% | +11,384 | New |
| Gillespie Robinson & Grimm Inc | 11,580 | $21.1K | 0.00% | +100+0.9% | Added |
| Dimensional Fund Advisors LP | 11,924 | $21.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,000 | $23.7K | 0.00% | +8,321+177.8% | Added |
| Resources Investment Advisors, LLC. | 14,550 | $26.5K | 0.00% | −3,400−18.9% | Reduced |
| Tower Research Capital LLC (TRC) | 15,300 | $27.8K | 0.00% | +3,789+32.9% | Added |
| Charles Schwab Investment Management Inc | 15,668 | $28.5K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,248 | $33.2K | 0.00% | 00.0% | Unchanged |
| Commerce Bank | 20,000 | $36.4K | 0.00% | 00.0% | Unchanged |
| Quinn Opportunity Partners LLC | 22,327 | $40.6K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 24,364 | $44.3K | 0.00% | +24,364 | New |
| Susquehanna International Group, LLP | 25,650 | $46.7K | 0.00% | −79,376−75.6% | Reduced |
| Two Sigma Investments, LP | 47,786 | $87.0K | 0.00% | −54,663−53.4% | Reduced |
| Hikari Power Ltd | 49,959 | $91.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 53,010 | $96.5K | 0.00% | +53,010 | New |
| Jackson Square Capital, LLC | 63,773 | $116.1K | 0.03% | 00.0% | Unchanged |
| Marshall Wace, LLP | 74,559 | $135.7K | 0.00% | +74,559 | New |
| Northern Trust Corp | 82,990 | $151.0K | 0.00% | +18,041+27.8% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 83,222 | $151.5K | 0.00% | −4,786−5.4% | Reduced |
| Two Sigma Advisers, LP | 113,400 | $206.4K | 0.00% | −71,700−38.7% | Reduced |
| State Street Corp | 120,303 | $219.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 127,300 | $231.7K | 0.01% | −97,000−43.2% | Reduced |
| Millennium Management LLC | 204,598 | $372.4K | 0.00% | +181,317+778.8% | Added |
| Morgan Stanley | 371,403 | $676.0K | 0.00% | +96,042+34.9% | Added |
| Towerview LLC | 400,000 | $728.0K | 0.48% | +17,500+4.6% | Added |
| Geode Capital Management, LLC | 460,140 | $837.6K | 0.00% | +88,377+23.8% | Added |
| BlackRock Inc. | 562,024 | $1.02M | 0.00% | +39,046+7.5% | Added |
| Renaissance Technologies LLC | 563,932 | $1.03M | 0.00% | −73,100−11.5% | Reduced |
| Vanguard Group Inc | 1,650,500 | $3.00M | 0.00% | +157,143+10.5% | Added |
| Adams Street Partners LLC | 3,275,616 | $5.96M | 2.46% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 5,964,510 | $10.9M | 0.04% | +5,964,510 | New |
| Samlyn Capital, LLC | 6,123,021 | $11.1M | 0.19% | +3,774,658+160.7% | Added |
| OrbiMed Advisors LLC | 6,943,654 | $12.6M | 0.27% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −361,406−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,570−100.0% | Sold out |
| Fortem Financial Group, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,604−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,378−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |